Menopause and Adhesive Capsulitis

Etiologically, primary adhesive capsulitis arises without an identifiable trigger and is often deemed idiopathic, whereas secondary adhesive capsulitis develops in the context of known precipitating factors such as trauma, surgery, prolonged immobilization, or systemic conditions⁽⁷⁾. Recognition of these epidemiological patterns and pathophysiological distinctions is particularly relevant in midlife women, in whom declining estrogen levels may influence inflammatory and fibrotic pathways within the shoulder capsule. Ultimately, understanding these distinctions is essential for assessing and managing midlife female athletes.

Estrogen plays a central regulatory role in musculoskeletal homeostasis, influencing collagen synthesis, matrix remodeling, and fibroblast activity via estrogen receptor (ER-α/ER-β) signaling pathways. Experimental data demonstrate that estrogen modulates collagen turnover and reduces excessive cross-link formation, thereby maintaining tissue compliance⁽⁸⁾. It is therefore not surprising that estrogen deficiency is associated with reduced fibrillar organization, increased stiffness, and altered extracellular matrix (ECM) remodeling dynamics⁽⁹⁾. Beyond its structural role, estrogen exerts important vascular and immunomodulatory effects. It enhances endothelial nitric oxide production, supports microvascular perfusion, and modulates inflammatory cytokine expression⁽¹⁰⁾.

Estrogen deficiency during menopause is associated with a shift toward a pro-inflammatory milieu and increased transforming growth factor-β (TGF-β) activity, both of which are key drivers of fibroblast proliferation and myofibroblast differentiation⁽¹¹⁾. Evidence from other tissues strengthens this biological plausibility. Postmenopausal women demonstrate increased rates of tendinopathy, alterations in pelvic floor connective tissue integrity, and increased dermal stiffness with reduced elasticity^(12-14). These findings reflect a systemic alteration in connective tissue behavior rather than isolated regional pathology. The glenohumeral capsule may be particularly vulnerable to these changes. Shoulder biomechanics rely heavily on capsular compliance for normal arthrokinematics, and capsular tissue is sensitive to inflammatory mediators. In a low-estrogen environment, the balance between collagen synthesis and adaptive remodeling may shift toward pathological cross-linking and fibrosis⁽¹²⁾. This theory is supported by histological studies of the capsular tissue in adhesive capsulitis, which demonstrate increased fibroblast density, myofibroblast differentiation, and upregulation of pro-fibrotic mediators⁽¹³⁾. Consequently, capsular fibrosis in midlife women may represent the musculoskeletal manifestation of a broader systemic endocrine-modulated process.

Menopause is accompanied by measurable metabolic and inflammatory changes. Declining estrogen is associated with increased visceral adiposity, reduced insulin sensitivity, altered glucose handling, and upregulation of pro-inflammatory cytokines⁽¹⁴⁾. These shifts occur even in lean, physically active women. The resultant subclinical insulin resistance may allow

advanced glycation end-products (AGEs) to accumulate within collagen matrices, increasing cross-link density and reducing tissue extensibility, similar to that seen in diabetic hyperglycemia^{(1, 19)}.

Unsurprisingly, a systematic review and meta-analysis have confirmed a strong relationship between frozen shoulder, metabolic, and inflammatory markers⁽¹⁵⁾. This cytokine-driven fibroblast activation, coupled with impaired inflammatory resolution, promotes persistent fibrosis rather than adaptive repair. From a clinical standpoint, this raises important considerations. In a metabolically and immunologically primed environment, aggressive loading strategies may exacerbate pain and irritability. Heightened nociceptive sensitivity, reduced tissue adaptability, and prolonged inflammatory signaling can result in symptom escalation rather than functional progression. Subsequently, adhesive capsulitis may be better conceptualized as a metabolic–inflammatory condition with a musculoskeletal expression, rather than a purely mechanical capsular contracture.

Estrogen also modulates nociceptive processing centrally and peripherally. It influences descending inhibitory pathways, neurotransmitter regulation, and inflammatory pain signaling. Reduced estrogen levels are associated with diminished endogenous pain inhibition and increased inflammatory pain sensitivity⁽¹⁶⁾. Given the shoulder capsule’s dependence on capsular compliance and its sensitivity to inflammatory mediators, these endocrine, inflammatory, and neurophysiological shifts may create a permissive environment for capsular fibrosis and persistent pain characteristic of adhesive capsulitis⁽¹⁷⁾.

Further, this pain perception may be aggravated by sleep disturbance, fatigue, mood fluctuation, and heightened stress reactivity, all factors known to frequently occur during the menopausal transition. These neuroendocrine interactions may help explain the characteristic clinical features of adhesive capsulitis in midlife women: severe night pain, pain disproportionate to measurable loss of motion, and heightened irritability with manual therapy or exercise. Importantly, pain behavior in this cohort should not be prematurely attributed to poor coping or nonspecific central sensitization. Hormone-mediated alterations in nociceptive modulation, layered upon a pro-fibrotic capsular process, offer a biologically coherent explanation for symptom severity.

In athletic and highly active women, adhesive capsulitis is frequently attributed to training load, minor trauma, or technical error. However, the menopausal transition is rarely screened despite its biological relevance to connective tissue remodeling, inflammation, and pain modulation⁽¹⁹⁾. Clinicians should include targeted questions regarding menstrual irregularity or recent cycle cessation, vasomotor symptoms, sleep disturbance, and history of early menopause, hysterectomy, or oophorectomy when assessing women aged 40–60 (see Figure 2). These variables may influence tissue irritability, recovery capacity, and rehabilitation response^(19-22).

Further, certain clinical features may indicate a systemic contribution. Bilateral or sequential shoulder involvement, rapid stiffness progression, disproportionate night pain, and poor response to otherwise appropriate rehabilitation should prompt broader consideration of metabolic and endocrine influences. The established association between adhesive capsulitis and metabolic dysfunction further supports this systems-based assessment approach⁽²⁰⁾.

Importantly, interdisciplinary awareness is essential. Collaboration with general practitioners, endocrinologists, and women’s health specialists may be appropriate when systemic symptoms coexist or when recovery deviates from expected trajectories. Ultimately, failure to consider menopausal status risks misclassification of pathology, mistimed loading strategies, and avoidable patient frustration.

Mechanical loading remains fundamental in musculoskeletal rehabilitation. However, in menopause-associated adhesive capsulitis, the biological context modifies tissue response to load. Estrogen deficiency, low-grade systemic inflammation, and altered nociceptive modulation may collectively reduce tissue adaptability while amplifying pain sensitivity^(19-22). Histological evidence demonstrates fibroblast proliferation and pro-fibrotic signaling within the capsule, suggesting that aggressive stretching or high-intensity mobilization may exacerbate symptoms during high-irritability phases^(16-18).

Expectation management is therefore critical. Symptom trajectories may be prolonged and fluctuate more than in purely mechanical shoulder conditions. Rehabilitation should prioritize symptom-guided loading, gradual exposure to range and strength development, and pain-informed progression rather than pain-provocation models.

Further, adjunctive strategies warrant equal emphasis. Optimizing sleep, addressing psychosocial stress, and educating patients regarding hormonal influences may reduce central amplification and improve adherence⁽¹⁸⁾. Where persistent severe night pain, rapid deterioration, or bilateral progression occur, escalation or referral should be considered (see Figure 3).

Adhesive capsulitis in midlife women may be more accurately conceptualized as a systemic inflammatory–fibrotic condition influenced by hormonal transition. Estrogen decline affects connective tissue regulation, metabolic balance, inflammatory signaling, and pain modulation; all mechanisms that converge within the glenohumeral capsule. Acknowledging menopause does not over-medicalize care; it contextualizes it. The challenge for clincians is to evolve beyond purely biomechanical models toward biologically informed rehabilitation strategies.